Filing Details
- Accession Number:
- 0001567619-19-017526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-23 16:36:53
- Reporting Period:
- 2019-08-22
- Accepted Time:
- 2019-08-23 16:36:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1505497 | Biorestorative Therapies Inc. | BRTX | Services-Misc Health & Allied Services, Nec (8090) | 911835664 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1527212 | Mark Weinreb | 40 Marcus Drive Melville NY 11747 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-22 | 1,700 | $0.29 | 81,700 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-22 | 1,300 | $0.26 | 83,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-22 | 2,000 | $0.24 | 85,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $0.75 | 2010-12-15 | 2020-12-14 | 4,000 | 4,000 | Direct |
Common Stock | Stock Option | $0.75 | 2022-02-09 | 50,000 | 50,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2022-12-07 | 20,000 | 20,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2023-10-04 | 12,500 | 12,500 | Direct | |
Common Stock | Stock Option | $0.75 | 2024-02-18 | 50,000 | 50,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2024-10-23 | 150,000 | 150,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2025-09-04 | 208,000 | 208,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2026-06-10 | 275,000 | 275,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2027-06-23 | 275,000 | 275,000 | Direct | |
Common Stock | Stock Option | $0.75 | 2028-10-29 | 275,000 | 275,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2020-12-14 | 4,000 | 4,000 | Direct |
2022-02-09 | 50,000 | 50,000 | Direct |
2022-12-07 | 20,000 | 20,000 | Direct |
2023-10-04 | 12,500 | 12,500 | Direct |
2024-02-18 | 50,000 | 50,000 | Direct |
2024-10-23 | 150,000 | 150,000 | Direct |
2025-09-04 | 208,000 | 208,000 | Direct |
2026-06-10 | 275,000 | 275,000 | Direct |
2027-06-23 | 275,000 | 275,000 | Direct |
2028-10-29 | 275,000 | 275,000 | Direct |
Footnotes
- The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014.
- The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013.
- The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
- The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016.
- The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
- The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018.
- The option is exercisable to the extent of 91,667 shares on each of June 10, 2016 and June 10, 2017, and 91,666 shares on June 10, 2018.
- The option is exercisable to the extent of 91,667 shares on each of June 23, 2017 and June 23, 2018, and 91,666 shares on June 23, 2019.
- The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020.